New National Brain Tumor Society Program Highlighted by White House Cancer Moonshot Today, the White House Cancer Moonshot announced several important and novel initiatives to advance progress towards ending cancer as we know it. Highlighted in this announcement was NBTS’s commitment, made at the first White House Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) & Diffuse Intrinsic Pontine Glioma (DIPG) during national Brain Tumor Awareness Month […] September 13, 2023
Leading Institute Joins Consortium on DNA Damage Response Treatments for Adults and Children with Brain Cancer Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced that Jann Sarkaria, MD, radiation oncologist, and co-leader of the Mayo Clinic Comprehensive Cancer Center Neuro-oncology program, is joining its DNA Damage Response Consortium. The consortium — which also comprises experts from St. Jude Children’s Research Hospital; Dana-Farber Cancer Institute; New […] August 31, 2023
Five Years of Glioblastoma Awareness Day: Five Advancements & Five Challenges The establishment of a national Glioblastoma (GBM) Awareness Day has, in many ways, driven significant progress for the GBM and entire brain tumor community. This year as we recognize the fifth annual Glioblastoma Awareness Day, it’s important that we take stock of these accomplishments, which have only been achievable through the dedicated advocacy and efforts […] July 20, 2023
Leading Brain Cancer Nonprofits Partner to Fund Innovative Research Projects Today, the National Brain Tumor Society, the nation’s largest nonprofit dedicated to defeating brain tumors and improving the lives of patients with brain tumors, and StacheStrong, a non-profit devoted to raising funds and awareness for brain cancer research, are announcing a partnership to collaboratively fund two innovative research projects. Combined, the groups are providing nearly […] July 19, 2023
Top Boston Hospitals Latest to Join Consortium Bringing Forward DNA Damage Response Treatments for Adults and Children with Brain Cancer Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced that experts from Dana-Farber Cancer Institute and Brigham & Women’s Hospital are joining its DNA Damage Response Consortium. The consortium — which also comprises teams from St. Jude Children’s Research Hospital; New York University Grossman School of Medicine (NYU); the University […] June 27, 2023